Ardelyx Inc.
- Biotech or pharma, therapeutic R&D
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx is pursuing strategic collaborations to develop and commercialize first-in-class medicines that help gastrointestinal and cardiorenal patients with unmet treatment needs within the U.S. as well as expand access to its currently marketed products to patients outside of the U.S.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}